Select Issuer Clients

Select Issuer Clients

Issuer Client Profile

InVivo Therapeutics Corp. (NVIV)

InVivo Therapeutics Corp. (NASDAQ:NVIV) is focused on utilizing polymers as a platform technology to develop and commercialize groundbreaking treatments for spinal cord injuries. InVivo’s technologies encompasses multiple strategies involving biomaterials, U.S. Food & Drug Administration (FDA) approved drugs, growth factors, and human neural stem cells (hNSCs).

View Website

Stock Info

InVivo Therapeutics Corp. NASDAQ: NVIV
Day Range
52 wk Range
Market Cap

Stock Quotes are delayed at least 15 minutes.

Issuer Client News Feed

For Investors

Want to take part in the next big idea?

Join Our Network

For Entrepreneurs

Want to explore how we add value?

Submit Your Business Plan